Richard Dowd, MD
Neurological Surgery · North Dartmouth, MANPI 1528446465
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,149 of the $12,409 with a category attached, or 81.8%. 9 manufacturers reported payments, led by Spineart USA Inc at 27.3% of the total. 2025 is the largest year on record at $12,183, more than ten times the $201 reported in 2023.
Across 66 payments — averaging $188.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineart USA Inc$3K
- Medtronic$3K
- VB Spine LLC$3K
- Alphatec Spine, Inc$3K
- Orthofix Medical, Inc.$79
- Medical Device Business Services, Inc.$69
- plus $79 from 3 others
What the payments were for
- Travel & lodging$10,14982%
- Food & beverage$2,26118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineart USA Inc | 6 | $3,387 |
| Medtronic | 23 | $3,221 |
| VB Spine LLC | 20 | $2,798 |
| Alphatec Spine, Inc | 10 | $2,777 |
| Orthofix Medical, Inc. | 1 | $79 |
| Medical Device Business Services, Inc. | 3 | $69 |
| Stryker | 1 | $32 |
| Boston Scientific | 1 | $25 |
| Novocure Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,409 in reported general payments places this provider in the 70th percentile of 183 neurological surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 29 | $189 |
| Gabapentin | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in North Dartmouth
- Matthew PhilipsNorth Dartmouth$247K
- Simcha WellerBoston$905K
- Paul HouleHyannis$774K
- Aman PatelBoston$734K
- Alireza AtriBoston$503K
- Frederik PenningsWorcester$471K
- Myron RolleBoston$290K
- Jeffrey ArleBurlington$284K
- John ChiBoston$280K
- Erica BissonBurlington$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.